Optimization of combinational intranasal drug delivery system for the management of migraine by using statistical design

European Journal of Pharmaceutical Sciences

Volumn 70, Issue , 2015, Pages 140-151

  Kumar, Animesh ^a   Garg, Tarun ^a   Sarma, Ganti S ^a   Rath, Goutam ^a   Goyal, Amit Kumar ^a  

^a ISF COLLEGE OF PHARMACY   (India)

Author keywords

Bioavailability; Box Behnken design; Controlled drug delivery; Muco adhesion; Nasal drug delivery

Indexed keywords

KETOROLAC TROMETAMOL; POLYMER; UNCLASSIFIED DRUG; XYLOGLUCAN; ZOLMITRIPTAN; ADHESIVE AGENT; GEL; KETOROLAC; OXAZOLIDINONE DERIVATIVE; TRYPTAMINE DERIVATIVE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; GEL; HISTOPATHOLOGY; MAXIMUM PLASMA CONCENTRATION; MIGRAINE; MUCOADHESION; NONHUMAN; NOSE MUCOSA; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; STATISTICAL MODEL; TEMPERATURE; TIME TO MAXIMUM PLASMA CONCENTRATION; ANIMAL; CHEMISTRY; DISEASE MANAGEMENT; DRUG EFFECTS; INTRANASAL DRUG ADMINISTRATION; METABOLISM; MIGRAINE DISORDERS; PROCEDURES; SHEEP;

ADHESIVES; ADMINISTRATION, INTRANASAL; ANIMALS; DISEASE MANAGEMENT; DRUG DELIVERY SYSTEMS; GELS; KETOROLAC; MIGRAINE DISORDERS; NASAL MUCOSA; OXAZOLIDINONES; SHEEP; TRYPTAMINES;

EID: 84923361880     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2015.01.012     Document Type: Article

References (27)

1. S. Abbasbandy, M. Yürüsoy, and H. Güllüce Analytical solutions of non-linear equations of power-law fluids of second grade over an infinite porous plate Mathe. Comput. Appl. 19 2014 124 133
2. F. Acarturk Mucoadhesive vaginal drug delivery systems Recent Pat. Drug Delivery Formulation 3 2009 193 205
3. Bianchini, P., Boldrini, E., Burgalassi, S., Giannaccini, B., Luciani, G., Saettone, M.F., 2000. Ophthalmic solutions viscosified with tamarind seed polysaccharide. Google Patents.
4. L.E. Bromberg, and E.S. Ron Temperature-responsive gels and thermogelling polymer matrices for protein and peptide delivery Adv. Drug Deliv. Rev. 31 1998 197 221
5. B.P. Depani, A.A. Naik, and H.A. Nair Preparation and evaluation of chitosan based thermoreversible gels for intraperitoneal delivery of 5-fluorouracil (5-FU) Acta Pharm. 63 2013 479 491
6. R. Dubey, L.G. Martini, and M. Christie Duel-acting subcutaneous microemulsion formulation for improved migraine treatment with zolmitriptan and diclofenac: formulation and in vitro-in vivo characterization AAPS J. 16 2014 214 220
7. M. Godbole, P.W. There, and P. Dangre Formulation and optimization of prolonged release nasal in situ gel for treatment of migraine Indo Am. J. Pharm. Res. 4 2014 1320 1332
8. S.A. Jain, D.S. Chauk, H.S. Mahajan, A.R. Tekade, and S.G. Gattani Formulation and evaluation of nasal mucoadhesive microspheres of sumatriptan succinate J. Microencapsul. 26 2009 711 721
9. M.M. Johnston, and A.M. Rapoport Triptans for the management of migraine Drugs 70 2010 1505 1518
10. A. Kempwade, and A. Taranalli Formulation and evaluation of thermoreversible, mucoadhesive in situ intranasal gel of rizatriptan benzoate J. Sol-Gel. Sci. Technol. 72 2014 43 48
11. R.J. Majithiya, P.K. Ghosh, M.L. Umrethia, and R.S. Murthy Thermoreversible-mucoadhesive gel for nasal delivery of sumatriptan AAPS Pharm. Sci. Technol. 7 2006 E80 E86
12. G. Martin Pre-clinical pharmacology of zolmitriptan (Zomig™; formerly 311C90), a centrally and peripherally acting 5HT1B/1D agonist for migraine Cephalalgia 17 1997 4 14
13. B. Menon, and N. Kinnera Prevalence and characteristics of migraine in medical students and its impact on their daily activities Ann. Indian Acad. Neurol. 16 2013 221
14. 1F receptor agonists: a new treatment option for migraine attacks? Neurotherapeutics 7 2010 176 182
15. S.A. Pagar Development and evaluation of in situ nasal mucoadhesive gel of metoprolol succinate by using 32 full factorial design Int. J. Pharm. Pharm. Sci. 2014
16. 12. Part I: Preformulation study Int. J. Pharm. 270 2004 37 45
17. S. Qian, Y.C. Wong, and Z. Zuo Development, characterization and application of in situ gel systems for intranasal delivery of tacrine Int. J. Pharm. 468 2014 272 282
18. Rao, P., Srivastava, H., Whistler, R., 1973. Industrial Gums. Whistler, R.L. (Ed.), pp. 372-411.
19. A. Rapoport Antimigraine drugs: new frontiers Neurol. Sci. 30 2009 49 54
20. S. Reagan-Shaw, M. Nihal, and N. Ahmad Dose translation from animal to human studies revisited FASEB J. 22 2008 659 661
21. I.R. Schmolka Artificial skin I. Preparation and properties of pluronic F-127 gels for treatment of burns J. Biomed. Mater. Res. 6 1972 571 582
22. D. Shivpuri, M. Rajesh, and D. Jain Prevalence and characteristics of migraine among adolescents: a questionnaire survey Indian Pediatr. 40 2003 665 669
23. R.M. Singh, A. Kumar, and K. Pathak Mucoadhesive in situ nasal gelling drug delivery systems for modulated drug delivery Expert Opin. Drug deliv. 10 2013 115 130
24. I. Tung Rheological behavior of poloxamer 407 aqueous solutions during sol-gel and dehydration processes Int. J. Pharm. 107 1994 85 90
25. C. van Hemelrijck, and C.C. Müller-Goymann Rheological characterization and permeation behavior of poloxamer 407-based systems containing 5-aminolevulinic acid for potential application in photodynamic therapy Int. J. Pharm. 437 2012 120 129
26. H.H. Winter, and F. Chambon Analysis of linear viscoelasticity of a crosslinking polymer at the gel point Journal of Rheology 30 1986 367 382 (1978-present)
27. N.M. Zaki, G.A. Awad, N.D. Mortada, and S.S. ABD ELHADY Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties Eur. J. Pharm. Sci. 32 2007 296 307